Free Trial vs Demo: Which CTA Fills a B2B Pipeline?

Most B2B sites ship both buttons. 'Start free trial' on the left, 'Book a demo' on the right, both in the hero, both in the nav. Then everyone wonders why neither number moves.

The usual content on this topic argues 'product-led vs sales-led' as a company-strategy question. That is not the fight you are having. The fight you are having is a page-level CTA decision with a conversion consequence, and it has a decision rule.

What does each CTA actually cost you in pipeline?

A demo request costs you volume; a free trial costs you control. Unbounce's 2024 Conversion Benchmark Report, built on more than 41,000 landing pages and 57 million conversions, puts the median SaaS landing-page conversion rate at 3.8% — 42% below the 6.6% median across all industries. B2B software already converts worse than almost everything else. Your CTA choice decides where the survivors land.

Think about pipeline as three multipliers, not one: how many visitors convert, how many of those are real buyers, and how fast a human can touch them. A trial maximises the first number. A demo maximises the second and third. Anything you pick trades one against the others.

That last row is where most sites sit. It is not a strategy. It is an unresolved argument between marketing and sales that got shipped to production.

At what ACV does a demo request start destroying more than it creates?

Our recommendation: below roughly $5,000 in annual contract value, a demo-only CTA destroys more pipeline than it creates — and above roughly $25,000 ACV, a trial-only CTA does. That is a judgment call we would defend, not a published statistic, so run the arithmetic yourself before you accept it.

Here is the arithmetic, with numbers you should replace with your own. Say 10,000 monthly visitors hit a bottom-funnel page. At the 3.8% SaaS median, a trial CTA gets you 380 signups. A demo CTA converts a smaller slice — call it a third of that in your own model — so roughly 125 booked calls.

Now price the labour. Those 125 calls need discovery, a demo, a follow-up and a proposal. At a $3,000 ACV, the fully loaded cost of a rep working that many deals eats the contract. At $40,000 ACV it is trivially worth it. The ACV number is not a marketing preference. It is the point where your sales cost per deal crosses the deal itself.

The middle band — roughly $5,000 to $25,000 — is where a hybrid earns its keep: trial as the primary CTA, with a 'talk to us' link for the buyer who already knows they need a contract, security review or a purchase order. Your pricing page is where that band gets sorted, because a buyer who can see your prices self-selects into the right motion.

What happens to conversion rate when you ship both CTAs at once?

You pay twice — once in conversion rate, once in your ability to learn anything. Unbounce, whose report covers 57 million conversions, tracks pages with 'mixed' conversion events (a click and a form on the same page) and states plainly that 'multiple conversion types on a landing page is typically not best practice.'

The first cost is decision friction. A visitor who arrived to evaluate your product now has to evaluate your buying process instead. Two equally weighted buttons make them stop and think, and thinking is where conversion goes to die.

The second cost is statistical. Split 380 monthly conversions across two CTAs and neither branch has enough volume to tell you anything within a quarter. You have not hedged. You have blinded yourself.

Both CTAs can live on a page. They just cannot both be primary. One button, one text link — the hierarchy is the decision.

Which CTA does organic search traffic actually want?

Organic traffic overwhelmingly wants the trial. Gartner's B2B buying research reports that 75% of B2B buyers prefer a rep-free sales experience, and in Gartner's survey of 148 technology-purchase decision-makers, 64% of buyers already familiar with a product or service preferred a 100% digital buying experience.

That matches how organic behaves. A person who found you at 11pm by searching a problem-shaped query is in research mode, alone, on their own clock. Handing them a calendar widget asks them to schedule a sales conversation about a product they have not seen yet. Most will close the tab.

Gartner is careful about the other half of that finding, and so should you be: it notes that self-service digital purchases are far more likely to end in purchase regret. 'Rep-free' is what buyers prefer, not always what serves them. Which is exactly why the demo does not disappear — it moves.

This is also the argument for building your SEO around bottom-funnel intent first. Traffic that arrives on a comparison or alternatives page is further along than traffic that arrives on a definition post, and it deserves a different CTA than your homepage default.

Why does your sales team keep asking for the demo button back?

Because a demo request hands them a named human on a calendar, and a trial signup hands them an email address and a hope. Gartner also found that B2B buyers are 1.8 times more likely to complete a high-quality deal when they use supplier-provided digital tools in partnership with a rep, rather than entirely on their own — so sales is not being irrational here.

This is the fight nobody writes about. Marketing owns the conversion-rate number. Sales owns the meetings number. The two CTAs optimize different KPIs, and the homepage ends up with both buttons because nobody wanted to lose the argument.

The resolution is not a compromise button. It is a shared definition: what does sales get, and when? If your trial fires a product-qualified-lead signal — invited a teammate, connected a data source, hit a usage threshold — sales gets a warmer call than any demo form produces, and they stop asking for the button.

If you cannot instrument that signal yet, be honest about it. Until you can, sales is right and the demo stays primary.

Can you run a trial and a demo without splitting your own traffic?

Yes — by ranking them per page instead of pairing them everywhere, and the cost of getting the ranking wrong is measurable. Zuko's form benchmarking database, covering over 93 million tracked sessions, puts the average form completion rate at 51.71% — so roughly half the people who start your demo form never finish it.

Then attack the friction inside whichever form you kept. Baymard Institute's 2024 research found the average e-commerce checkout contains 11.3 form fields while most sites need only 8, and that the number of fields affects usability far more than the number of steps. A demo form asking for company size, job title, budget and timeline is a qualification survey wearing a CTA's clothes.

Cut it to name, work email and one open question. Our own guides on how many form fields is too many and multi-step versus single-step forms go deeper — the short version is that the fields you delete get answered on the call anyway.

How do you test this when you have almost no traffic?

You mostly cannot A/B test it, and pretending otherwise is how teams burn a quarter. At the 3.8% SaaS median, detecting a modest relative lift takes thousands of sessions per variant — which for a site doing a few thousand visits a month means months of runtime before the test is even readable.

So do this instead. Run a sequential swap: one CTA for six weeks, the other for six weeks, same season, same traffic mix, and compare. It is a weaker design than a split test — it cannot control for seasonality or a launch — but it is honest about being weak, which a badly powered A/B test is not.

And change what you measure. Do not compare CTA click rates. Compare the number of qualified sales conversations each CTA produced 30 days later, and the revenue that followed 90 days after that. A trial that triples your signups and closes nothing has lost the test. Our post on A/B testing low-traffic sites covers the sample-size math in full.

The cheapest test of all costs nothing: read your own inbound. Count how many people this quarter emailed sales asking for a trial, and how many trial users emailed asking for a call. Whichever direction people are already dragging themselves in, that is the CTA your market wants. Your visitors have been telling you the answer in support tickets while you argued about it in a meeting.

One more honest gap: nobody has published a credible dataset on how AI-search referrals behave on CTAs specifically. Pew Research Center's tracking of 900 US adults across 68,879 Google searches found that when an AI summary appeared, users clicked a search result on just 8% of visits versus 15% without one — fewer clicks, arriving later in the decision. Segment those referrals in your analytics and watch them yourself, rather than trusting anyone's guess.

Free trial vs demo: the honest verdict

For most US B2B software below roughly $25,000 ACV: free trial as the primary CTA, demo as a secondary text link. Above that band, invert it — demo primary, trial as a sandbox you offer during the sales process. Freemium is a distribution strategy, not a CTA, and should only be on the table if your product gets better with more users.

The dual CTA is the only option that is wrong at every ACV. If you cannot choose, you have not decided who you sell to.

If your site is running both buttons and neither is producing conversations, the problem is architecture, not copy. That is what our conversion-focused website design work fixes: one primary action per page, routed by intent, instrumented so you can see which CTA produced revenue and not just clicks. Get my free audit and we will tell you which button is costing you pipeline.